Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice (Q47865542)

6 February 2018

title

Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice (English)

1 reference

6 February 2018

Luiz Alexandre Viana Magno

1 reference

5

1 reference

6 February 2018

Jean-Martin Beaulieu

8

1 reference

6 February 2018

Stella Manta

4

object named as

Stella Manta

1 reference

6 February 2018

author name string

Thomas Del'Guidice

1

1 reference

6 February 2018

Morgane Lemasson

2

1 reference

6 February 2018

Adeline Etiévant

3

1 reference

6 February 2018

Guy Escoffier

6

1 reference

6 February 2018

François S Roman

7

1 reference

6 February 2018

publication date

3 August 2013

1 reference

6 February 2018

published in

Psychopharmacology

1 reference

6 February 2018

volume

231

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

109-122

1 reference

6 February 2018

Neurotransmitter transporters: recent progress

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Animal models of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

The molecular genetics of executive function: role of monoamine system genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Hotspots of large rare deletions in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Interneurons produced in adulthood are required for the normal functioning of the olfactory bulb network and for the execution of selected olfactory behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009-2011: focus on clinical efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Perseveration related to frontal lesion in mice using the olfactory H-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Do High Doses of Stimulants Impair Flexible Thinking in Attention-Deficit Hyperactivity Disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Dopamine transporter mutant mice in experimental neuropharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Genetics of childhood disorders: XXIV. ADHD, part 8: hyperdopaminergic mice as an animal model of ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Diversity and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Molecular characterization of the dopamine transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Food-reinforced operant behavior in dopamine transporter knockout mice: enhanced resistance to extinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Serotonin and decision making processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Comparison of single-dose and extended methamphetamine administration on reversal learning in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Academic doping or Viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Atomoxetine and neuropsychological function in children with attention-deficit/hyperactivity disorder: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Tricyclic antidepressants (TCA) may improve atomoxetine's efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

The neuropsychopharmacology of fronto-executive function: monoaminergic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Animal models of attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Relationship between psychostimulant-induced "high" and dopamine transporter occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

The Neurobiology of Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3212-8

Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance

21 January 2018

1 reference

12 December 2020

Therapeutic Potential of 5-HT2CReceptor Ligands

1 reference

12 December 2020

Nonstimulants and emerging treatments in adults with ADHD

1 reference

12 December 2020

Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines

1 reference

12 December 2020

Genetic and neurobiological aspects of attention deficit hyperactive disorder: a review.

1 reference

12 December 2020

Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice

1 reference

12 December 2020

Monoamine transporter as a target molecule for psychostimulants

1 reference

12 December 2020

Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys

1 reference

12 December 2020

Clinical review: evidence-based diagnosis and treatment of ADHD in children.

1 reference

12 December 2020

Attention-deficit hyperactivity disorder

1 reference

12 December 2020

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review

1 reference

12 December 2020

Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls

1 reference

12 December 2020

Pharmacotherapy of ADHD in adults.

1 reference

12 December 2020

Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter

1 reference

12 December 2020

Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers

1 reference

12 December 2020

Novel treatments for attention-deficit/hyperactivity disorder in children.

1 reference

12 December 2020

Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists

1 reference

12 December 2020

Neuropsychological impairments in adult attention deficit hyperactivity disorder: a literature review

1 reference

12 December 2020

Diagnosis and treatment of the hyperactive child

1 reference

12 December 2020

10.1007/S00213-013-3212-8

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018